Primo Lara
About
In The Last Decade
Primo Lara
22 papers receiving 179 citations
Peers
Comparison fields: 5 of 36
- Pulmonary and Respiratory Medicine 103
- Oncology 96
- Molecular Biology 68
- Surgery 54
- Cancer Research 34
Countries citing papers authored by Primo Lara
This map shows the geographic impact of Primo Lara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Primo Lara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Primo Lara more than expected).
Fields of papers citing papers by Primo Lara
This network shows the impact of papers produced by Primo Lara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Primo Lara. The network helps show where Primo Lara may publish in the future.
Co-authorship network of co-authors of Primo Lara
This figure shows the co-authorship network connecting the top 25 collaborators of Primo Lara. A scholar is included among the top collaborators of Primo Lara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Primo Lara. Primo Lara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 26 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 18 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 13 | |
| 13 | 9 | |
| 14 | DIVERGENT ACTIVITY OF AFATINIB (AFAT) AND CETUXIMAB (CET) IN PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF ACQUIRED ERLOTINIB RESISTANCE. | 2 |
| 15 | 5 | |
| 16 | 26 | |
| 17 | 7 | |
| 18 | 12 | |
| 19 | 2 | |
| 20 | 20 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.